Hirotaka Yoshida Selected Research

propyl O-beta galactopyranosyl-(1-4)-O-beta galactopyranosyl-(1-4)-alpha galactopyranoside

4/2007

The novel Tau mutation G335S: clinical, neuropathological and molecular characterization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirotaka Yoshida Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 07/2004
5	Tauopathies 01/2020 - 11/2002
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012 - 07/2004
2	Neuroblastoma 01/2020 - 03/2018
2	Dementia (Dementias) 01/2012 - 02/2006
2	Parkinsonian Disorders (Parkinsonism) 10/2006 - 11/2002
2	Frontotemporal Dementia (Semantic Dementia) 10/2006 - 11/2002
2	Pick Disease of the Brain (Pick's Disease) 10/2006 - 11/2003
1	Glaucoma 01/2020
1	Hemorrhage 01/2020
1	Hyperhomocysteinemia 03/2018
1	Ideomotor Apraxia 04/2007
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2006
1	Corticobasal Degeneration 10/2006
1	Multiple System Atrophy 02/2006
1	Parkinson Disease (Parkinson's Disease) 02/2006

Drug/Important Bio-Agent (IBA)

4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2012 - 07/2004
2	tau Proteins (tau Protein)IBA 01/2020 - 11/2002
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2020 - 03/2018
2	sarkosylIBA 11/2003 - 11/2002
1	pitavastatin (itavastatin)FDA Link 01/2020
1	K-115IBA 01/2020
1	fasudil (AT 877)IBA 01/2020
1	HomocysteineIBA 03/2018
1	propyl O-beta galactopyranosyl-(1-4)-O-beta galactopyranosyl-(1-4)-alpha galactopyranosideIBA 04/2007
1	alpha-SynucleinIBA 02/2006
1	Protein Kinases (Protein Kinase)IBA 07/2004
1	Protein Isoforms (Isoforms)IBA 11/2002